Wockhardt Ltd — Capital/Financing Update 2022

Mar 3, 2022

3[rd] March, 2022

Ref. No.: WOCK/SEC/SE/2021-22/134

==> picture [167 x 46] intentionally omitted <==

BSE Limited Corporate Relations Department P J Towers Dalal Street Mumbai - 400 001

Scrip Code: 532300

National Stock Exchange of India Limited Exchange Plaza Bandra Kurla Complex Bandra (E) Mumbai - 400 051 NSE Symbol: WOCKPHARMA

Dear Sir/Madam,

Subject: Update on intimation dated 3[rd] March 2022 under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (“SEBI Listing Regulations”).

Further to our letter no. WOCK/SEC/SE/2021-22/133 dated 3[rd] March, 2022, informing about the terms and conditions of the Rights issue duly approved by the Members of the Capital Raising Committee of the Board of Directors of the Company, we wish to inform you that the Company has obtained International Securities Identification Number (ISIN): INE049B20017 for the purpose of credit of the rights entitlements in accordance with the provisions of Regulation 77A of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 read with relevant circulars in this regard issued by Securities and Exchange Board of India from time to time.

Kindly take the above information on record.

Thanking you,

for Wockhardt Limited

==> picture [111 x 53] intentionally omitted <==

Debashis Dey Company Secretary

==> picture [106 x 46] intentionally omitted <==

==> picture [482 x 30] intentionally omitted <==